Seventure Partners

A European venture capital firm investing in life sciences and digital technologies.

Venture Capital Active Paris, France Est. 1997
Visit website ↗ LinkedIn
Last updated 2026-07-20
Portfolio
2
in our dataset
Rounds participated
2
Rounds led
0
Rounds' value
$12.8M
total disclosed, rounds participated
Stages
B Round, E Round, F Round, Pre-Seed, Seed, A Round, G Round, C Round, D Round

About

Seventure Partners is a leading European venture capital firm established in 1997, specializing in high-growth potential businesses within the fields of Life Sciences and Digital Technologies. The firm actively supports innovative companies that aim to generate positive impacts on humankind, society, sustainability, and the planet. Seventure Partners manages approximately €1 billion in assets as of June 30, 2024, and has a strong presence in Europe, Israel, Asia, and North America. They invest across various stages, including seed, venture capital, pre-IPO, and late-stage growth.

Portfolio · 2

Inspecto
Early Detection of Food Contaminants
1 round $850K committed Latest: 2018-12
DayTwo
Precision Nutrition for Metabolic Disease
1 round $12.0M committed Latest: 2017-06

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences2
Agriculture & Food Technologies1
Business Software1

Funds · 5

  • Fund — $240M Apr 2020
  • Fund — $28M Mar 2018
  • Fund — $66M Jan 2018
  • Fund — $190M Jan 2014
  • Fund — $67M Nov 2013

Q&A

What is Seventure Partners' primary focus in terms of investment sectors?
Seventure Partners actively funds innovative companies within Digital technologies and Life sciences.
When was Seventure Partners founded?
Seventure Partners was founded in 1997.
What is Seventure Partners' AUM as of the end of 2020?
As of the end of 2020, Seventure Partners had 850 million net commitments under management.
Can you name a notable exit for Seventure Partners?
Seventure Partners had an exit with BiomX in November 2019, which involved a Reverse Merger Event and is listed on the NYSE.
Which portfolio companies are notable for Seventure Partners?
Seventure Partners' portfolio includes BiomX, a company focused on microbiome therapies, and DayTwo, which specializes in precision nutrition for metabolic disease.
What is Seventure Partners' most recent fund close?
Seventure Partners closed a fund of $240M in April 2020.
What investment stages does Seventure Partners typically engage in?
Seventure Partners invests across various stages including Pre-Seed, Seed, A Round, B Round, C Round, D Round, E Round, F Round, and G Round.
Who is a key executive at Seventure Partners?
Isabelle de Cremoux serves as the CEO & Managing Partner at Seventure Partners.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)